Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.48 USD | -3.66% | -4.85% | +5.87% |
05-07 | Inozyme Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-08 | Transcript : Inozyme Pharma, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.87% | 288M | |
+19.30% | 47.02B | |
+48.77% | 41.86B | |
+0.31% | 41.76B | |
-4.27% | 28.8B | |
+11.84% | 26.05B | |
-21.87% | 19.15B | |
+4.07% | 12.55B | |
+29.43% | 12.34B | |
-3.74% | 11.82B |
- Stock Market
- Equities
- INZY Stock
- News Inozyme Pharma, Inc.
- HC Wainwright Lowers Inozyme Pharma's Price Target to $20 From $33, Maintains Buy Rating